HOMA-IR
Clinical trials for HOMA-IR explained in plain language.
Never miss a new study
Get alerted when new HOMA-IR trials appear
Sign up with your email to follow new studies for HOMA-IR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo pill aims to melt fat, not muscle, in weight loss
Disease control Recruiting nowThis Phase 2b trial tests whether adding enobosarm (a muscle-preserving drug) to semaglutide (a weight-loss drug) helps older adults lose more fat and keep muscle. About 200 people aged 65 and older who are overweight or obese will take both drugs or semaglutide alone. The goal i…
Matched conditions: HOMA-IR
Phase: PHASE2 • Sponsor: Veru Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Lipedema pain mystery: could your metabolism be the key?
Knowledge-focused Recruiting nowThis study looks at how metabolic markers like insulin resistance and body measurements relate to pain and central sensitization in women with lipedema. Researchers will assess 59 women using questionnaires and physical measurements. The goal is to better understand these connect…
Matched conditions: HOMA-IR
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC